Mary Kay Fenton

2007 - Achillion Pharmaceuticals

In 2007, Mary Kay Fenton earned a total compensation of $413.1K as Vice President and Chief Financial Officer at Achillion Pharmaceuticals, a 52% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$46,500
Option Awards$160,273
Salary$200,000
Other$6,281
Total$413,054

Fenton received $200K in salary, accounting for 48% of the total pay in 2007.

Fenton also received $46.5K in non-equity incentive plan, $160.3K in option awards and $6.3K in other compensation.

Rankings

In 2007, Mary Kay Fenton's compensation ranked 6,636th out of 8,700 executives tracked by ExecPay. In other words, Fenton earned more than 23.7% of executives.

ClassificationRankingPercentile
All
6,636
out of 8,700
24th
Division
Manufacturing
2,539
out of 3,314
23rd
Major group
Chemicals And Allied Products
570
out of 746
24th
Industry group
Drugs
404
out of 546
26th
Industry
Pharmaceutical Preparations
289
out of 364
21st
Source: SEC filing on April 24, 2008.

Fenton's colleagues

We found four more compensation records of executives who worked with Mary Kay Fenton at Achillion Pharmaceuticals in 2007.

2007

Michael Kishbauch

Achillion Pharmaceuticals

Chief Executive Officer

2007

Milind Deshpande

Achillion Pharmaceuticals

Chief Scientific Officer

2007

Gautam Shah

Achillion Pharmaceuticals

Senior Vice President and Chief Compliance Officer

2007

John Pottage

Achillion Pharmaceuticals

Chief Medical Officer

News

You may also like